Secondaries announced 7.25.2016
IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating. Company: Chembio Diagnostics, Inc. Symbol: CEMI Price: Last trade $8.45 Trade Date: 7/29 Shares: 1.2 million Underwriter(s) Craig-Hallum Capital Group Co Manager(s)[…]